PFM
Privium Fund Management Portfolio holdings
AUM
$556M
1-Year Est. Return
169.21%
1 Year Est. Return
+169.21%
AUM
$556M
AUM Growth
+$92.8M
(+20%)
Holding
63
Top Buys
| 1 | +$9.71M | |
| 2 | +$7.76M | |
| 3 | +$6.1M | |
| 4 |
AST SpaceMobile
ASTS
|
+$5.4M |
| 5 |
Biogen
BIIB
|
+$4.4M |
Top Sells
| 1 | +$27.4M | |
| 2 | +$13.3M | |
| 3 | +$8.94M | |
| 4 |
Arrowhead Research
ARWR
|
+$4.77M |
| 5 |
uniQure
QURE
|
+$3.59M |
Sector Composition
| 1 | Consumer Discretionary | 30.53% |
| 2 | Healthcare | 25.52% |
| 3 | Technology | 23.08% |
| 4 | Communication Services | 11.92% |
| 5 | Financials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
51
Autolus Therapeutics
AUTL
$423M
| $503K | 0.09% |
308,837
+14,695
|
|
||
52
Taysha Gene Therapies
TSHA
$1.49B
| $441K | 0.08% |
134,900
|
|
||
53
Fate Therapeutics
FATE
$123M
| $420K | 0.08% |
333,219
+222,129
|
|
||
54
Valaris
VAL
$4.12B
| $406K | 0.07% |
8,315
-5,488
|
|
||
55
Noble Corp
NE
$5.07B
| $404K | 0.07% |
14,287
|
|
||
56
Transocean
RIG
$4.89B
| $318K | 0.06% |
+102,000
|
|
||
57
Sibanye-Stillwater
SBSW
$8.83B
| $295K | 0.05% |
26,232
-7,808
|
|
||
58
Tidewater
TDW
$2.83B
| $292K | 0.05% |
5,483
+133
|
|
||
59
Voyager Therapeutics
VYGR
$240M
| $210K | 0.04% |
45,000
+19,759
|
|
||
60
Carvana
CVNA
$63.4B
| – | – |
-5,000
|
|
||
61
Dyne Therapeutics
DYN
$3.17B
| – | – |
-27,566
|
|
||
|
EMX
62
DELISTED
EMX Royalty
EMX
| – | – |
-216,968
|
|
||
63
Sarepta Therapeutics
SRPT
$2.29B
| – | – |
-39,400
|
|